08

Feb

Neimeth raised N3.68bn via Rights Issue, to allot 2.37bn bonus shares

Neimeth International Pharmaceutical Plc has notified the Nigerian Exchange and the investing public that following close of its Rights Issue exercise on September 15, 2022 that it has received a No Objection from the Securities and Exchange Commission on the allotment of 2,373,947,500 ordinary shares at N1.55 per share on the basis of 5 new Ordinary Shares […]